GNQ Insilico Inc. (“GNQ” or the “Company”), a corporation formed under the federal laws of Canada, and IB Acquisition Corp. (Nasdaq: IBAC) (“IBAC”), a Nevada special purpose acquisition company, announce that they have entered into a definitive business combination agreement (the “BCA”) pursuant to which IBAC will acquire all of the issued and outstanding shares in the capital of GNQ by way of a statutory plan of arrangement under the Canada Business Corporations Act (the “Transaction”). GNQ’s mission is to revolutionize drug development by leveraging artificial intelligence, digital twin technology, advanced biological modeling, and quantum computing to enable precision medicine at scale.
Read the full article: GNQ Insilico Inc. to Go Public through Business Combination with IB Acquisition Corp. //
Source: https://www.globenewswire.com/news-release/2026/03/16/3256597/0/en/GNQ-Insilico-Inc-to-go-Public-Through-Business-Combination-With-IB-Acquisition-Corp-NASDAQ-IBAC.html